To become a global API/ Intermediate producing organization and to be recognized as the leading Bulk Drug player in the industry by assuring high quality standards and cost effectiveness .
To work towards Health of Human beings by manufacturing and delivering best quality APIs/Bulk Drug produced by adopting innovative technologies.
M/s. Medicore Generics., promoted by a team of professionals having 30 years rich experience in the API industry and clear vision and is conscious about long term sustainable value-added growth. M/s. Medicore Generics has proposed to establish an up a medium scale Bulk Drugs and Intermediates manufacturing facility in a 9400 SMT site in Amaravati MIDC. Company is established in year 2021.
We have adopted CSR policy in compliance with the requirements of the Companies Act, 2013 and Companies (Corporate Social Responsibilities) Rules 2014 notified by Central Government. Our CSR activities are monitored by the CSR Committee of the Board.
The CSR Committee Comprises of following Directors:
Our CSR efforts are in line with the provisions of Schedule VII of the Companies Act, 2013.Our focus area include:
Management Commitment
Our Board of Directors, our Management and all of our employees subscribe to the philosophy of compassionate care. We believe and act on an ethos of generosity and compassion, characterized by willingness to build a society that works for everyone. This is the cornerstone of our CSR policy.
